Stuart Kolinski Net Worth & Insider Trades

Stuart Kolinski - SVP General Counsel and Secret, Regeneron Pharmaceuticals Inc

As of June 7, 2010

What is Stuart Kolinski's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals Inc's SVP General Counsel and Secret, Stuart Kolinski, is estimated to be about $9.86M . Stuart Kolinski owns about 13,907 units of Regeneron Pharmaceuticals Inc common stock. In the last 7 years at Regeneron Pharmaceuticals Inc, Stuart Kolinski has sold an estimated value of $1.04M worth.

What is Stuart Kolinski's Past Insider Trading?

Stuart Kolinski's largest purchase order was 12,314 units , worth over $104.67K on February 4, 2010. Stuart Kolinski's largest sale order was 12,314 units , worth over $337.34K on February 4, 2010. In total, Stuart Kolinski has made about 19 transactions over 7 years of their time at Regeneron Pharmaceuticals Inc. Stuart Kolinski usually trades in December, with the busiest year in 2005.

Stuart Kolinski

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Regeneron Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals Inc's Past Insider Trades?

Regeneron Pharmaceuticals Inc's most recent insider trade came on February 3, 2023 by Arthur F Ryan who sold 100 units worth $75.61K . In the last 20 years, insiders at Regeneron Pharmaceuticals Inc have sold an estimated value of $17.5B and bought an estimated value of $3.52B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1